![Riam Shammaa](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cargos activos de Riam Shammaa
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
DEFENCE THERAPEUTICS INC. | Director/Miembro de la Junta | 09/11/2021 | - |
Independent Dir/Board Member | 09/11/2021 | - | |
IntelliStem Technologies, Inc.
![]() IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Director Ejecutivo | 04/02/2019 | - |
Fundador | 04/02/2019 | - |
Historial de carrera de Riam Shammaa
Antiguos cargos conocidos de Riam Shammaa.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Pallianera Pharma, Inc. | Fundador | - | - |
Estadísticas
Internacional
Canadá | 4 |
Operativa
Founder | 2 |
Chief Executive Officer | 1 |
Director/Board Member | 1 |
Sectorial
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
DEFENCE THERAPEUTICS INC. | Health Technology |
Empresas privadas | 2 |
---|---|
IntelliStem Technologies, Inc.
![]() IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Health Technology |
Pallianera Pharma, Inc. |
- Bolsa de valores
- Insiders
- Riam Shammaa
- Experiencia